Surrey researchers Sign in
Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients
Journal article   Peer reviewed

Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients

Frank G Sandmann, Laura Shallcross, Natalie Adams, David J Allen, Pietro G Coen, Annette Jeanes, Zisis Kozlakidis, Lesley Larkin, Fatima Wurie, Julie V Robotham, …
Clinical infectious diseases, Vol.67(5), pp.693-700
16/08/2018
PMID: 29529135

Abstract

and Commentaries
Since the introduction of rotavirus vaccination in England in July 2013, norovirus has become the second-largest contributor of inpatient gastroenteritis, preventing 57800 patients from being admitted annually. Economic costs amount to £297.7 million, which translates into 6300 quality-adjusted life years.
url
https://doi.org/10.1093/cid/ciy167View
Published (Version of record) Open

Metrics

Details

Usage Policy